The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).

摘要: Abstract Background Harm reduction is an evidence-based, effective response to HIV transmission and other harms faced by people who inject drugs, explicitly supported the Global Fund Fight AIDS, Tuberculosis Malaria. In spite of this, drugs continue have poor inequitable access these services face widespread stigma discrimination. 2013, launched a new funding model-signalling end previous rounds-based model that had operated since its founding in 2002. This study updates analyses assess investments harm interventions for duration model, from 2002 2014. Methods TB/HIV grant documents 2014 were reviewed identify grants contained activities drugs. Data collected detailed budgets, relevant budget lines recorded analysed determine resources allocated different specifically targeted at Results 151 58 countries, plus one regional proposal, targeting drugs–for total investment US$ 620million. Two-thirds this budgeted amount was "comprehensive package" defined United Nations. 91% identified Eastern Europe Asia. Conclusion represents updated, comprehensive assessment (2002) until start (2014). It also highlights overall shortfall funding, with estimated global need being 2.3billion 2015 alone. Using baseline, must carefully monitor ensure are maintained or scaled-up. There concerns regarding withdrawal middle-income countries where remains essential unfunded through sources: example, 15% which now ineligible support.